In this litigation over two patents for pain-killers that are engineered to combat abuse of opioid pain prescription medicines, an Abingdon U.S. District Court issues its opinion construing certain claims after a Markman proceeding.
The patents at the center of this dispute are both entitled “Tamper-Resistant Oral Opioid Agonist Formulations” and are owned by defendant Purdue ...